Oncostatin M in rheumatoid arthritis: a key cytokine acts synergistically with other proinflammatory cytokines to promote human cartilage loss

Lignende værker

• Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-α, Oncostatin M and response to biologic therapies
  af: Moran, Ellen M, et al.
  Udgivet: (2009)
• The value of serum type II collagen epitope measurement in assessing early clinical response to treatment with anti-tumour necrosis factor alpha therapy in rheumatoid arthritis
  af: Mullan, RH, et al.
  Udgivet: (2005)
• Synergistic interactions of proinflammatory cytokines with oncostatin M: implications for joint destruction
  af: Cawston, T, et al.
  Udgivet: (2003)
• Mechanisms of cartilage matrix turnover: synergistic interactions of proinflammatory cytokines with oncostatin M in upregulating matrix metalloproteinases and ADAMTS metalloproteinases
  af: Cawston, TE, et al.
  Udgivet: (2005)
• Production of angiotensin converting enzyme by rheumatoid synovial membrane.
  af: Veale, D, et al.
  Udgivet: (1992)